Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by SR Feldman
Comparison of Persistence Between Adults With Psoriasis Initiating Apremilast or Biologics
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Treatment Persistence in Psoriasis Patients Initiated on Apremilast, Oral Systemics, or Biologic Therapies
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Pss23 - Switch Patterns and Total Costs in Biologic-Naive Patients Initiating Apremilast or a Biologic for the Treatment of Psoriasis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Dermoscopic Features of Nail Psoriasis Treated With Biologics
Journal of Dermatology
Dermatology
Medicine
Predicting Treatment Success With Biologics in Psoriasis
British Journal of Dermatology
Dermatology
Medicine
Psoriasis-Arthritis – Apremilast: Kein Zusatznutzen Ableitbar
Aktuelle Rheumatologie
Rheumatology
Utility of Apremilast in the Treatment of Psoriasis
International Journal of Basic & Clinical Pharmacology
Biologics in the Management of Psoriasis
Clinical, Cosmetic and Investigational Dermatology
Dermatology
The Devil Is in the Data: Differences in Drug Persistence Between SNIIRAM, the French National Health Insurance Database, and Psoriasis Biologics Intervention Registers
British Journal of Dermatology
Dermatology
Medicine
211 Adults With Psoriasis Receive More Opioid Prescriptions Than Adults Without Psoriasis
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
